A De-Novo drug design and ADMET study to design small molecule stabilisers targeting mutant (V210I) human prion protein against familial Creutzfeldt-Jakob disease (fCJD).
Rafat AlamG. M. Sayedur RahmanNahid HasanAbu Sayeed ChowdhuryPublished in: Int. J. Comput. Biol. Drug Des. (2020)